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Plethysmography is an ever increasing test 
being performed at Mater Dei Hospital. The aim of 
the study was to obtain descriptive data regarding 
plethysmography in the Maltese population as well 
as to investigate the association of these lung 



































282 patients who had plethysmography 
between June 2015 and March 2016 at Mater Dei 
Hospital were enrolled in the study. The indications 
for referral, demographic data, lung function 
parameters, white cell count (WCC), urea, 
potassium and fasting blood glucose were noted. 
The mean BMI of the population cohort was 29.06 
(SD +/- 6.16). BMI was found to be negatively 
correlated to serum potassium levels (r=-0.14) and 
residual volume (r=-0.2).  Diffuse lung capcicity of 
Oxygen (DLCO), total lung capacity and forced 
expiratory flow in one second were negatively 
correlated to the WCC (r=-0.2, r=-0.17 and r=-0.12 
respectively) in the population. The current study 
confirms a significant association between lung 
function testing, diabetes, BMI and total serum 
white cell count after correcting for confounding 
factors.   This highlights the need for clinicians to 
be more aware of the possibility of underlying lung 
disease in these patients. A good clinical evaluation 
using history and examination of such patients is 
essential so as to identify which patients should be 
referred for lung function testing.  Such early 
referrals could potentially avoid progression of 
undiagnosed lung disease thus reducing the burden 
on the health care service with particular emphasis 
on acute hospital admissions and respiratory 
outpatient clinics.  
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Introduction 
Whole body plethysmography is the test of 
choice whenever information regards absolute lung 
volumes is required in addition to the spirometry 
results. Plethysmography should be performed on 
patients with suspected restrictive lung diseases 
where the measured lung volumes can help to 
differentiate between an obstructive and a 
restrictive pattern. Plethysmography is also useful 
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in the evaluation of obstructive lung diseases such 
as cystic fibrosis and bullous emphysema as well as 
to assess the resistance to airflow. Moreover, it can 
be used during the course of the disease where it 
aids in assessing the response to treatment.1 
Due to the challenges associated with 
performing and interpreting plethysmographies and 
the ever increasing amount of referrals for 
plethysmography at Mater Dei Hospital this study 
primarily aims to obtain descriptive statistics 
associated with plethysmography for the first time 
in Malta including appropriateness of referral. The 
secondary aim of the study was to investigate the 
association between lung function testing and 
various biochemical parameters thus helping 
clinicians during the overall evaluation of patients.  
Materials and Method: 
Patients 
A total of 282 patients who had a 
plethysmography at the Mater Dei Pulmonary 
Function laboratory were included in this 
retrospective study. All patients who had 
plethysmography between June 2015 and March 
2016 were included in the study, after permission to 
collect patient data was obtained from the hospital 
and data protection. Data collection included 
indications for referral,  demographic data including 
age, gender, height and weight, total lung capacity 
(TLC), residual volume (RV), diffusion lung 
capacity for carbon monoxide (DLCO), forced 
expiratory volume in the 1st second (FEV1), forced 
vital capacity (FVC) and the FEV1 and FVC ratio. 
Blood investigations including urea and 
creatinine, potassium, sodium, calcium, phosphate, 
magnesium, haemoglobin, white cell count, 
platelets, as well as fasting blood glucose and 
glycated haemoglobin taken within 2 months from 
the plethysmography study date were reviewed and 
documented for each patient. Data from the 
plethysmography test of patients who did not have 
any blood results were still collected for the 
purposes of studying the demographics of patients 
referred for plethysmogtaphy yet were then 
excluded in studying the associations of lung 
volumes to biochemical parameters. Previous chest 
X rays, Thoracic CT Scans and High resolution CT 
scans were reviewed in order to confirm underlying 
diagnosis. 
Statistic 
Patients were then subdivided according to the 
indication for which they were referred for 
plethysmography and the average age, weight, 
height and BMI for the male and female 
participants of each population were worked out 
together with standard deviation of the respective 
parameters.  Weight, height and BMI are mandatory 
parameters for performing lung function testing and 
therefore all lung function tests reviewed had these 
patient parameters included. 
The mean values were used for all parameters 
included in the study since normality testing 
showed a normal distribution of data. The Pearson 
correlation was performed to investigate (i) the 
linear correlation of age, height, weight and BMI 
with renal profile, electrolytes, CBC and 
plethysmography parameters and (ii) the linear 
correlation of DLCO, TLC, RV, FEV1 and FVC 
with renal profile, electrolytes, CBC and 
plethysmography parameters. Double sided P-
values were worked out.  
Multiple regression analysis was carried out to 
investigate any interdependencies between the 
variables studied and to further evaluate the 
association between DLCO and weight, height, 
BMI, urea, creatinine, potassium, sodium, 
haemoglobin, platelets and WCC.   
Analysis was performed using EXCEL13 and 
p-values of less than 0.05 were considered to be
statistically significant.
Results 
Demographic information of the patient cohort 
are as presented in Table 1.  
Demographic data 
A total of 153 males and 129 females 
participated in this study. A total of 43 patients 
were referred in view of diagnosis other than 
chronic obstructive pulmonary disease (COPD) or 
fibrosis (shown in Table 2 and Table 3) and these 
included asthma, bronchiectasis, pleural plaques, 
sarcoidosis, systemic sclerosis or neuromuscular 
disorders. In 54 of patients, no indication was 
documented on the referral ticket for 
plethysmography.  
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Table 1: Demographics of the cohort population: Means, standard deviation and 95% CI for the 
demographic, biochemical and lung function parameters 




Age 66 12.45 1.47 
Weight 75.77 18.83 2.22 
Height 161.13 9.65 1.14 
BMI 29.06 6.16 0.72 
Urea 6.96 4.97 0.59 
Creatinine 87.49 43.35 5.14 
Potassium 4.78 0.03 0.07 
Sodium 141.03 4.12 0.49 
Phosphate 1.11 0.23 0.04 
Magnesium 0.83 0.13 0.06 
Fasting Blood Glucose 6.08 1.87 0.26 
HbA1c 45.9% 12.12 1.94 
White cell count (WCC) 8.66 2.96 0.35 
Haemoglobin 13.81 1.57 0.18 
Platelets 268.24 104.97 12.46 
Total Lung capacity (TLC) 103.9% 40.35 4.82 
Residual volume (RV) 133.6% 98.50 11.80 
Forced Expiratory Volume 
in 1s (FEV1) 
72.3% 49.47 6.07 
Forced vital capacity (FVC) 67.9% 29.07 3.49 
FEV1/FVC 75.4% 17.28 2.12 
Diffuse lung capacity 
(DLCO) 
70.7% 32.33 4.11 
Table 2: Indication for referral for body plethysmography: 
The greatest indication was in patients with lung fibrosis. Gender distribution is also shown. (COPD – chronic 
obstructive pulmonary disease) 






Fibrosis 42.6% 49.2% 50.8% 
COPD 18.4% 86.5% 13.5% 
Hypersensitivity pneumonitis 4.6% 30.7% 69.2% 
Other diagnosis incl. asthma, bronchiectasis, 
pleural plaques 
15.3% 
No diagnosis found 19.1% 
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Table 3: Age, BMI and DLCO in the commonest presenting pathologies 
Obesity has been noted across all the different groups as shown above. 
 
 Mean Age Mean BMI Mean DLCO % 
Disease Male Female Male Female Male Female 
COPD 70.16 72.14 26.93 26.23 74 47 
Fibrosis 68.23 67.93 29.42 28.64 64 62 
Hypersensitivity 
pneumonitis 
52.50 65.89 34.49 35.79 54 69 
 
 
Table 4: Pearson Correlate between the variables studied 
A statistically significant negative correlation was noted between the HbA1c and RV and FVC. There is also a 
negative correlation between FVC and urea. A clinically significant positive correlation between FVC and 
sodium was also noted. 
(RV: residual volume, FVC: forced vital capacity, HbA1c (glycated haemoglobin) 
 
Parameters R value P value 
RV to Hba1c -0.27 0.00077 
FVC to Urea -0.13 0.02 
FVC to Sodium 0.13 0.04 
FVC to Hba1c -0.166 0.04 
 
 
Figure 1: Multiple regression analysis showing the relationship of white cell count (WCC) and diffuse 
lung capacity of CO (DLCO): A statistically significant negative correlation was found showing that with 
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The mean BMI of the population cohort studied 
was 29.06 (SD +/- 6.15).  BMI was negatively 
correlated with serum potassium levels (r=-0.14, 
p=0.02) and positively correlated with calcium 
levels (r=0.21, p=0.02) after correcting for any 
confounding factors. Both TLC (r=-0.19, p=0.002) 
and RV (r=-0.2, p=0.001) were negatively 
correlated to BMI.  
Plethysmography 
The total mean white cell count of the studied 
population, was negatively correlated with the mean 
DLCO levels (r=-0.2 and p=0.002).  
A similar association was also noted between 
the TLC and WCC (r=-0.17, p=0.006) and between 
FEV1 and WCC (r=-0.12, p=0.05). Other 
associations between different parameters were also 
noted as documented in Table 4. No significant 
association was noted between DLCO and HbA1c 
(r=-0.06, p=0.52) or haemoglobin (r=0.06, p=0.32).  
Multiple Regression Analysis 
The association found between the DLCO and 
the WCC was confirmed when controlling for other 
factors including the weight, height, BMI, urea, 
creatinine, potassium, sodium, haemoglobin and 
platelets as shown in Figure 1. An R2 value of 0.84 
and a p value of 0.0004.     
Discussion 
In this first retrospective study targeting 
patients referred to Mater Dei Hospital for 
plethysmography, a total of 282 patients with 
respiratory disease, were investigated.  
The study is the first large cohort, population 
based study relating the plethysmography results to 
the metabolic profile. One of the benefits of Malta 
being a small island, with one general hospital, is 
that all patients requiring plethysmography were 
referred to the same medical center. Moreover, the 
service is not provided in private hospitals and thus 
all patients requiring the test are referred to Mater 
Dei. This provided both lab and operator 
standardization hence, eliminating inter-operational 
and calibration errors. 
All the patients referred for this investigation in 
the current study were suffering from chronic 
respiratory diseases such as pulmonary fibrosis, 
chronic obstructive pulmonary disease and asthma. 
These results highlight the need to better understand 
the indications of when a plethysmography study is 
needed during the clinical work up of patients since 
nearly 20% of referred patients were suffering from 
obstructive airway diseases only. This highlights 
the importance of not using this type of 
investigation in the management of such patients 
unless a specific indication such as review of 
diagnosis or lung transplant work up is being 
considered. The authors suggest the inclusion of a 
checklist contain the main indications for 
plethysmography on the current lung function test 
referral form.  One limitation of this study is that no 
data regarding justification of referral of such 
patients for plethysmography was available since 
patients’ clinical files were not accessed.  
In Malta, like in many westernized countries, 
obesity is an increasing problem with an estimated 
69.75% of the Maltese population being overweight 
or obese.2 Obesity affects lung volumes with a 
negative correlation observed between increasing 
BMI and expiratory reserve volume (ERV) and 
functional residual capacity (FRC).3 FRC in the 
obese individual is also linked to airway resistance 
and airway conductance. Airway resistance 
increases with an increasing BMI and this might 
lead to obesity-related problems with breathing. The 
total lung capacity (TLC), residual volume (RV) 
and vital capacity (VC) decrease proportionately 
with an increase in weight while an increase in 
DLCO is associated with increasing BMI.3 
The current study demonstrates that the TLC, 
FEV1 and DLCO was found to have a significant 
negative correlation with the total the peripheral 
white cell count (p=0.002).  Multiple studies have 
also shown that peripheral leucocyte numbers are 
significantly higher among smokers versus non-
/former smokers4-11 contrary to what other evidence 
that suggests that the negative association between 
serum leucocyte count and FEV1 is independent of 
smoking status.4,11-14 Studies have shown that serum 
leucocyte count is also significantly inversely 
correlated with FVC.4, 12 This trend was also noted 
in our study, however the results were not found to 
be statistically significant. One potential limitation 
of the current study is that the differential white cell 
count was not investigated since serum neutrophil 
counts have been associated with a decrease in 
DLCO.15 
Results from two longitudinal studies over a 
period of years affirm that raised serum leucocytes 
are not only related to poor initial pulmonary 
function, but are moreover a predictor of follow up 
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decline in lung function12-13 and a  significant 
predictor for respiratory symptoms both among 
smokers and non-smokers. [16] A low FEV1 and a 
raised WCC have both been shown to be 
independent predictors of increased all cause 
mortality rate. [11] Our findings are thus in keeping 
with those of previous studies suggesting that the 
serum leucocyte count is an important independent 
determinant of lung function, irrespective of 
smoking status.4, 15 
Since the prevalence of diabetes in the Maltese 
population is 10.39% [1] the current study has 
focused on the association between lung function 
tests and diabetes. Results showed that worsening 
glucose control, as measured by glycated 
haemoglobin level, was significantly associated 
with a low RV and low FVC. Two studies reported 
a similar relationship between Hba1c and FVC [17] 
while multiple studies have shown that pulmonary 
function is indeed reduced in patients with both 
type 1 and type 2 diabetes mellitus.17-20 Patients 
with a decreased RV have restrictive lung disease 
for which long-term steroids are prescribed. 
Steroids are known to have a profound effect on 
glucose metabolism and hence, it is essential that 
patients receiving therapy have their Hba1c 
monitored regularly.  
There is however conflicting evidence 
regarding the relationship between Hba1c and lung 
function tests. In fact, some evidence suggests that 
duration of diabetes is a more significant factor for 
poor respiratory function.18,20-22 Conversely, 
research also shows that lung function is inversely 
related to the risk of future diabetes.23–27 Of note is 
that diabetes is a significant influencer for low 
DLCO.19-22 This trend has been observed in our 
study but was not found to be statistically 
significant.  
The lack of data regarding the smoking status 
of patients participating in the study as well as the 
presence of multiple comorbidities that might be 
affecting the results are potential limitations of the 
study.  
The current study confirms a significant 
association between lung function testing, diabetes, 
BMI and total serum white cell count after 
correcting for confounding factors.  This is of 
particular relevance in the Maltese population 
which has a high prevalence of obesity and diabetes 
when compared to other European countries. Since 
most of the patients recruited in the study were of 
Maltese background (as stipulated from their ID 
numbers), the authors propose that there might be 
an underlying genetic, environmental and 
geographical predisposition to pulmonary pathology 
in this cohort of patients.  This highlights the need 
for clinicians to be more aware of the possibility of 
underlying lung disease in these patients. A good 
clinical evaluation using history and examination of 
such patients is essential so as to identify which 
patients should be referred for lung function testing. 
Such early referrals could potentially avoid 
progression of undiagnosed lung disease thus 
reducing the burden on the health care service with 
particular emphasis on acute hospital admissions 
and respiratory outpatient clinics.  
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